1-3 of 3
Chelo Rayon, PhD
Close
Sort by
Journal Articles

Secondary Acute Myeloid Leukemia and Myelodysplastic Syndromes Following ATRA and Anthracycline Monochemotherapy Treatment for Acute Promyelocytic Leukemia.

Pau Montesinos, MD, Jose D. Gonzalez, PHD, Chelo Rayon, PHD, Javier de la Serna, PHD, Juan Bergua, PHD, Jordi Esteve, PHD, Mar Tormo, PHD, Edo Vellenga, PHD, Elena Amutio, PHD, Guillermo Deben, PHD, Miguel Sanz, PHD
Journal: Blood
Blood (2007) 110 (11): 1838.
https://doi.org/10.1182/blood.V110.11.1838.1838
Published: 2007
Journal Articles

Risk-Adapted Treatment of Acute Promyelocytic Leukemia: Updated Results of the Spanish PETHEMA LPA99 Trial Using ATRA and Anthracycline Monochemotherapy.

Miguel A. Sanz, PhD, Pau Montesinos, MD, Edo Vellenga, PhD, Chelo Rayon, PhD, Ricardo Parody, PhD, Javier de la Serna, PhD, Juan Bergua, PhD, Angel Leon, PhD, Silvia Negri, PhD, Concha Rivas, PhD, Salut Brunet, PhD, Marcos Gonzalez, PhD, Jordi Esteve, PhD, Bob Lowenberg, PhD
Journal: Blood
Blood (2007) 110 (11): 590.
https://doi.org/10.1182/blood.V110.11.590.590
Published: 2007
Journal Articles

Central Nervous System Relapse in Patients with Acute Promyelocytic Leukemia Treated with All-Trans Retinoic Acid and Reinforced Anthracycline Monochemotherapy.

Pau Montesinos, MD, Jose D. Gonzalez, PHD, Edo Vellenga, PHD, Chelo Rayon, PHD, Ricardo Parody, PHD, Angel Leon, PHD, Jordi Esteve, PHD, Juan Bergua, PHD, Gustavo Milone, PHD, Miguel A. Sanz, PHD
Journal: Blood
Blood (2007) 110 (11): 592.
https://doi.org/10.1182/blood.V110.11.592.592
Published: 2007